Skip to content
TirzepatideReport
Providers

Tracked provider

Claya tirzepatide review

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

This is a tracked entry: the facts below are what Claya publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-06-06). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on Claya's own site before you pay.

What it costs

Tirzepatide
$299/mo (compounded)
What is dispensed
Compounded tirzepatide
Who compounds it
503A

How the program works

An online intake is reviewed by a licensed clinician. Publishes its price before you start the intake.

What we like

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

The caveats

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

Ready to look at Claya directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit Claya

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

Other tirzepatide programs we track

← Every provider review